Global Bladder Cancer Targeted Drug Supply, Demand and Key Producers, 2023-2029

Page: 100

Published Date: 03 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Bladder Cancer Targeted Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. This type of treatment blocks the growth and spread of cancer cells and tries to limit damage to healthy cells.

This report studies the global Bladder Cancer Targeted Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Bladder Cancer Targeted Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bladder Cancer Targeted Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Bladder Cancer Targeted Drug total market, 2018-2029, (USD Million)
Global Bladder Cancer Targeted Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Bladder Cancer Targeted Drug total market, key domestic companies and share, (USD Million)
Global Bladder Cancer Targeted Drug revenue by player and market share 2018-2023, (USD Million)
Global Bladder Cancer Targeted Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Bladder Cancer Targeted Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Bladder Cancer Targeted Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck KGaA, Roche, Astellas, Janssen Biotech, Bristol-Myers Squibb, Merck & Co. and Gilead Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bladder Cancer Targeted Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Bladder Cancer Targeted Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Bladder Cancer Targeted Drug Market, Segmentation by Type
Atezolizumab (Tecentriq)
Avelumab (Bavencio)
Erdafitinib (Balversa)
Other

Global Bladder Cancer Targeted Drug Market, Segmentation by Application
Hospital
Retail Pharmacy
Other

Companies Profiled:
Pfizer
Merck KGaA
Roche
Astellas
Janssen Biotech
Bristol-Myers Squibb
Merck & Co.
Gilead Sciences

Key Questions Answered
1. How big is the global Bladder Cancer Targeted Drug market?
2. What is the demand of the global Bladder Cancer Targeted Drug market?
3. What is the year over year growth of the global Bladder Cancer Targeted Drug market?
4. What is the total value of the global Bladder Cancer Targeted Drug market?
5. Who are the major players in the global Bladder Cancer Targeted Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Bladder Cancer Targeted Drug Introduction
    1.2 World Bladder Cancer Targeted Drug Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Bladder Cancer Targeted Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Bladder Cancer Targeted Drug Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Bladder Cancer Targeted Drug Market Size (2018-2029)
        1.3.3 China Bladder Cancer Targeted Drug Market Size (2018-2029)
        1.3.4 Europe Bladder Cancer Targeted Drug Market Size (2018-2029)
        1.3.5 Japan Bladder Cancer Targeted Drug Market Size (2018-2029)
        1.3.6 South Korea Bladder Cancer Targeted Drug Market Size (2018-2029)
        1.3.7 ASEAN Bladder Cancer Targeted Drug Market Size (2018-2029)
        1.3.8 India Bladder Cancer Targeted Drug Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Bladder Cancer Targeted Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Bladder Cancer Targeted Drug Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Bladder Cancer Targeted Drug Consumption Value (2018-2029)
    2.2 World Bladder Cancer Targeted Drug Consumption Value by Region
        2.2.1 World Bladder Cancer Targeted Drug Consumption Value by Region (2018-2023)
        2.2.2 World Bladder Cancer Targeted Drug Consumption Value Forecast by Region (2024-2029)
    2.3 United States Bladder Cancer Targeted Drug Consumption Value (2018-2029)
    2.4 China Bladder Cancer Targeted Drug Consumption Value (2018-2029)
    2.5 Europe Bladder Cancer Targeted Drug Consumption Value (2018-2029)
    2.6 Japan Bladder Cancer Targeted Drug Consumption Value (2018-2029)
    2.7 South Korea Bladder Cancer Targeted Drug Consumption Value (2018-2029)
    2.8 ASEAN Bladder Cancer Targeted Drug Consumption Value (2018-2029)
    2.9 India Bladder Cancer Targeted Drug Consumption Value (2018-2029)

3 World Bladder Cancer Targeted Drug Companies Competitive Analysis
    3.1 World Bladder Cancer Targeted Drug Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Bladder Cancer Targeted Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Bladder Cancer Targeted Drug in 2022
        3.2.3 Global Concentration Ratios (CR8) for Bladder Cancer Targeted Drug in 2022
    3.3 Bladder Cancer Targeted Drug Company Evaluation Quadrant
    3.4 Bladder Cancer Targeted Drug Market: Overall Company Footprint Analysis
        3.4.1 Bladder Cancer Targeted Drug Market: Region Footprint
        3.4.2 Bladder Cancer Targeted Drug Market: Company Product Type Footprint
        3.4.3 Bladder Cancer Targeted Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Bladder Cancer Targeted Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Bladder Cancer Targeted Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Bladder Cancer Targeted Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Bladder Cancer Targeted Drug Consumption Value Comparison
        4.2.1 United States VS China: Bladder Cancer Targeted Drug Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Bladder Cancer Targeted Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Bladder Cancer Targeted Drug Companies and Market Share, 2018-2023
        4.3.1 United States Based Bladder Cancer Targeted Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Bladder Cancer Targeted Drug Revenue, (2018-2023)
    4.4 China Based Companies Bladder Cancer Targeted Drug Revenue and Market Share, 2018-2023
        4.4.1 China Based Bladder Cancer Targeted Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Bladder Cancer Targeted Drug Revenue, (2018-2023)
    4.5 Rest of World Based Bladder Cancer Targeted Drug Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Bladder Cancer Targeted Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Bladder Cancer Targeted Drug Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Bladder Cancer Targeted Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Atezolizumab (Tecentriq)
        5.2.2 Avelumab (Bavencio)
        5.2.3 Erdafitinib (Balversa)
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Bladder Cancer Targeted Drug Market Size by Type (2018-2023)
        5.3.2 World Bladder Cancer Targeted Drug Market Size by Type (2024-2029)
        5.3.3 World Bladder Cancer Targeted Drug Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Bladder Cancer Targeted Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Bladder Cancer Targeted Drug Market Size by Application (2018-2023)
        6.3.2 World Bladder Cancer Targeted Drug Market Size by Application (2024-2029)
        6.3.3 World Bladder Cancer Targeted Drug Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Bladder Cancer Targeted Drug Product and Services
        7.1.4 Pfizer Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 Merck KGaA
        7.2.1 Merck KGaA Details
        7.2.2 Merck KGaA Major Business
        7.2.3 Merck KGaA Bladder Cancer Targeted Drug Product and Services
        7.2.4 Merck KGaA Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Merck KGaA Recent Developments/Updates
        7.2.6 Merck KGaA Competitive Strengths & Weaknesses
    7.3 Roche
        7.3.1 Roche Details
        7.3.2 Roche Major Business
        7.3.3 Roche Bladder Cancer Targeted Drug Product and Services
        7.3.4 Roche Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Roche Recent Developments/Updates
        7.3.6 Roche Competitive Strengths & Weaknesses
    7.4 Astellas
        7.4.1 Astellas Details
        7.4.2 Astellas Major Business
        7.4.3 Astellas Bladder Cancer Targeted Drug Product and Services
        7.4.4 Astellas Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Astellas Recent Developments/Updates
        7.4.6 Astellas Competitive Strengths & Weaknesses
    7.5 Janssen Biotech
        7.5.1 Janssen Biotech Details
        7.5.2 Janssen Biotech Major Business
        7.5.3 Janssen Biotech Bladder Cancer Targeted Drug Product and Services
        7.5.4 Janssen Biotech Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Janssen Biotech Recent Developments/Updates
        7.5.6 Janssen Biotech Competitive Strengths & Weaknesses
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Details
        7.6.2 Bristol-Myers Squibb Major Business
        7.6.3 Bristol-Myers Squibb Bladder Cancer Targeted Drug Product and Services
        7.6.4 Bristol-Myers Squibb Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Bristol-Myers Squibb Recent Developments/Updates
        7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.7 Merck & Co.
        7.7.1 Merck & Co. Details
        7.7.2 Merck & Co. Major Business
        7.7.3 Merck & Co. Bladder Cancer Targeted Drug Product and Services
        7.7.4 Merck & Co. Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Merck & Co. Recent Developments/Updates
        7.7.6 Merck & Co. Competitive Strengths & Weaknesses
    7.8 Gilead Sciences
        7.8.1 Gilead Sciences Details
        7.8.2 Gilead Sciences Major Business
        7.8.3 Gilead Sciences Bladder Cancer Targeted Drug Product and Services
        7.8.4 Gilead Sciences Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Gilead Sciences Recent Developments/Updates
        7.8.6 Gilead Sciences Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Bladder Cancer Targeted Drug Industry Chain
    8.2 Bladder Cancer Targeted Drug Upstream Analysis
    8.3 Bladder Cancer Targeted Drug Midstream Analysis
    8.4 Bladder Cancer Targeted Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Bladder Cancer Targeted Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Bladder Cancer Targeted Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Bladder Cancer Targeted Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Bladder Cancer Targeted Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Bladder Cancer Targeted Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Bladder Cancer Targeted Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Bladder Cancer Targeted Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Bladder Cancer Targeted Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Bladder Cancer Targeted Drug Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Bladder Cancer Targeted Drug Players in 2022
    Table 12. World Bladder Cancer Targeted Drug Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Bladder Cancer Targeted Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Bladder Cancer Targeted Drug Player
    Table 15. Bladder Cancer Targeted Drug Market: Company Product Type Footprint
    Table 16. Bladder Cancer Targeted Drug Market: Company Product Application Footprint
    Table 17. Bladder Cancer Targeted Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Bladder Cancer Targeted Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Bladder Cancer Targeted Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Bladder Cancer Targeted Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Bladder Cancer Targeted Drug Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Bladder Cancer Targeted Drug Revenue Market Share (2018-2023)
    Table 23. China Based Bladder Cancer Targeted Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Bladder Cancer Targeted Drug Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Bladder Cancer Targeted Drug Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Bladder Cancer Targeted Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Bladder Cancer Targeted Drug Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Bladder Cancer Targeted Drug Revenue Market Share (2018-2023)
    Table 29. World Bladder Cancer Targeted Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Bladder Cancer Targeted Drug Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Bladder Cancer Targeted Drug Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Bladder Cancer Targeted Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Bladder Cancer Targeted Drug Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Bladder Cancer Targeted Drug Market Size by Application (2024-2029) & (USD Million)
    Table 35. Pfizer Basic Information, Area Served and Competitors
    Table 36. Pfizer Major Business
    Table 37. Pfizer Bladder Cancer Targeted Drug Product and Services
    Table 38. Pfizer Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Pfizer Recent Developments/Updates
    Table 40. Pfizer Competitive Strengths & Weaknesses
    Table 41. Merck KGaA Basic Information, Area Served and Competitors
    Table 42. Merck KGaA Major Business
    Table 43. Merck KGaA Bladder Cancer Targeted Drug Product and Services
    Table 44. Merck KGaA Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Merck KGaA Recent Developments/Updates
    Table 46. Merck KGaA Competitive Strengths & Weaknesses
    Table 47. Roche Basic Information, Area Served and Competitors
    Table 48. Roche Major Business
    Table 49. Roche Bladder Cancer Targeted Drug Product and Services
    Table 50. Roche Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Roche Recent Developments/Updates
    Table 52. Roche Competitive Strengths & Weaknesses
    Table 53. Astellas Basic Information, Area Served and Competitors
    Table 54. Astellas Major Business
    Table 55. Astellas Bladder Cancer Targeted Drug Product and Services
    Table 56. Astellas Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Astellas Recent Developments/Updates
    Table 58. Astellas Competitive Strengths & Weaknesses
    Table 59. Janssen Biotech Basic Information, Area Served and Competitors
    Table 60. Janssen Biotech Major Business
    Table 61. Janssen Biotech Bladder Cancer Targeted Drug Product and Services
    Table 62. Janssen Biotech Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Janssen Biotech Recent Developments/Updates
    Table 64. Janssen Biotech Competitive Strengths & Weaknesses
    Table 65. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 66. Bristol-Myers Squibb Major Business
    Table 67. Bristol-Myers Squibb Bladder Cancer Targeted Drug Product and Services
    Table 68. Bristol-Myers Squibb Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Bristol-Myers Squibb Recent Developments/Updates
    Table 70. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 71. Merck & Co. Basic Information, Area Served and Competitors
    Table 72. Merck & Co. Major Business
    Table 73. Merck & Co. Bladder Cancer Targeted Drug Product and Services
    Table 74. Merck & Co. Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Merck & Co. Recent Developments/Updates
    Table 76. Gilead Sciences Basic Information, Area Served and Competitors
    Table 77. Gilead Sciences Major Business
    Table 78. Gilead Sciences Bladder Cancer Targeted Drug Product and Services
    Table 79. Gilead Sciences Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 80. Global Key Players of Bladder Cancer Targeted Drug Upstream (Raw Materials)
    Table 81. Bladder Cancer Targeted Drug Typical Customers
List of Figure
    Figure 1. Bladder Cancer Targeted Drug Picture
    Figure 2. World Bladder Cancer Targeted Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Bladder Cancer Targeted Drug Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Bladder Cancer Targeted Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Bladder Cancer Targeted Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Bladder Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Bladder Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Bladder Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Bladder Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Bladder Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Bladder Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Bladder Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
    Figure 13. Bladder Cancer Targeted Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Bladder Cancer Targeted Drug Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Bladder Cancer Targeted Drug by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Bladder Cancer Targeted Drug Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Bladder Cancer Targeted Drug Markets in 2022
    Figure 27. United States VS China: Bladder Cancer Targeted Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Bladder Cancer Targeted Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Bladder Cancer Targeted Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Bladder Cancer Targeted Drug Market Size Market Share by Type in 2022
    Figure 31. Atezolizumab (Tecentriq)
    Figure 32. Avelumab (Bavencio)
    Figure 33. Erdafitinib (Balversa)
    Figure 34. Other
    Figure 35. World Bladder Cancer Targeted Drug Market Size Market Share by Type (2018-2029)
    Figure 36. World Bladder Cancer Targeted Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Bladder Cancer Targeted Drug Market Size Market Share by Application in 2022
    Figure 38. Hospital
    Figure 39. Retail Pharmacy
    Figure 40. Other
    Figure 41. Bladder Cancer Targeted Drug Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Bladder Cancer Targeted Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Bladder Cancer Targeted Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Pharma & Healthcare

Global Bladder Cancer Targeted Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Bladder Cancer Targeted Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 05 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Bladder Cancer Targeted Drug market size was valued at USD 779.9 million in 2023 and is forecast to a readjusted size of USD 1408 million by 2030 with a CAGR of 8.8% during review period.

Global Bladder Cancer Targeted Drug Supply, Demand and Key Producers, 2024-2030

Global Bladder Cancer Targeted Drug Supply, Demand and Key Producers, 2024-2030

date 24 Feb 2024

date Pharma & Healthcare

The global Bladder Cancer Targeted Drug market size is expected to reach $ 1408 million by 2030, rising at a market growth of 8.8% CAGR during the forecast period (2024-2030).

Global Bladder Cancer Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Bladder Cancer Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

date 13 Jan 2025

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Bladder Cancer Targeted Drug market size was valued at US$ 929 million in 2024 and is forecast to a readjusted size of USD 1686 million by 2031 with a CAGR of 9.0% during review period.

Product Tags

Bladder Cancer Targeted Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>